Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM SHS
Shares, excl. options Q2 2024
158M
Holdings value Q2 2024
$354M
Value change Q2 2024
+$33.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
102
Number of buys Q2 2024
20
Number of sells Q2 2024
-5
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.5M $3.01M +$149K $2.01 26
2024 Q2 158M $354M +$33.9M $2.24 102
2024 Q1 140M $402M +$33.4M $2.87 106
2023 Q4 130M $230M -$12.3M $1.77 85
2023 Q3 130M $410M +$376M $3.16 61
2023 Q2 13.7M $9.05M -$2.01M $0.66 37
2023 Q1 16.7M $13.3M -$3.03M $0.80 42
2022 Q4 19.4M $43.8M +$12.4M $2.26 51
2022 Q3 13.9M $27M -$1.81M $1.93 49
2022 Q2 14.7M $54.7M -$11.6M $3.72 55
2022 Q1 17M $111M -$16.2M $6.52 70
2021 Q4 18.5M $216M -$15.4M $11.65 64
2021 Q3 19.4M $362M +$4.4M $18.62 48
2021 Q2 18.3M $388M +$15M $21.20 48
2021 Q1 17.7M $359M -$11.6M $20.30 46
2020 Q4 18M $475M +$32M $26.54 51
2020 Q3 16.6M $367M +$367M $22.40 46